The development and successful approval and distribution of new drugs and therapies increasingly relies on the strategic partnerships forged across pharma, biotech, academia, tech and beyond. At the same time globalization, digital transformation, economic factors, and other industry forces are bringing about more mergers and acquisitions, and partnerships between vastly different organizations. For these partnerships to be successful and mutually beneficial, alliance management must manage the process and people efficiently and effectively. The quantity, scope, and complexity of these alliances has ushered in new alliance models, innovative strategies, and best practices to maximize value.
Cambridge Healthtech Institute’s 20th Annual Strategic Alliance Management Congress will bring together alliance management, business development, project management, technology transfer, licensing professionals and consultants to network and share experiences, best practices, tools, insights, and perspectives in the art of building and managing relationships and optimizing the value of your partnership portfolio.